Finance

Palantir (NASDAQ: PLTR) Posts Jaw-Dropping Rule Of 40 Score, But A 33X Sales Multiple Demands Perfection

Viridian Therapeutics, Inc. (VRDN) Discusses VRDN-008 Phase I Results and FcRn Portfolio Development Plans - Slideshow

S&P 500, Dow, Nasdaq End Lower Amid Nvidia Turmoil, But Record Best Week Since August — SPCX, NVDA, ARM, AZN In Focus

Is a bottom in for the Nasdaq-100? Charts to watch